Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma...

Por Juengel, Eva, Engler, Johanna, Natsheh, Iyad, Jones, Jon, Mickuckyte, Ausra, Hudak, Lukasz, Jonas, Dietger, Blaheta, Roman A
Publicado em 2009

Mycophenolate mofetil modulates adhesion receptors of the beta1 integrin family on tumor cells: impact on tumor recurrence and malignancy

Por Engl, Tobias, Makarević, Jasmina, Relja, Borna, Natsheh, Iyad, Müller, Iris, Beecken, Wolf-Dietrich, Jonas, Dietger, Blaheta, Roman A
Publicado em 2005

Mechanisms behind Temsirolimus Resistance Causing Reactivated Growth and Invasive Behavior of Bladder Cancer Cells In Vitro

Por Juengel, Eva, Natsheh, Iyad, Najafi, Ramin, Rutz, Jochen, Tsaur, Igor, Haferkamp, Axel, Chun, Felix K.-H., Blaheta, Roman A.
Publicado no Cancers (Basel) (2019)

HDAC-inhibition counteracts everolimus resistance in renal cell carcinoma in vitro by diminishing cdk2 and cyclin A

Por Juengel, Eva, Nowaz, Snigdha, Makarevi, Jasmina, Natsheh, Iyad, Werner, Isabella, Nelson, Karen, Reiter, Michael, Tsaur, Igor, Mani, Jens, Harder, Sebastian, Bartsch, Georg, Haferkamp, Axel, Blaheta, Roman A
Publicado em 2014